Paper Details

  1. Home
  2. Paper Details

Linagliptin: the newest dipeptidyl peptidase-4 inhibitor for type 2 diabetes mellitus.

Author: AlettiRachael, Cheng-LaiAngela

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Linagliptin is a DPP-4 inhibitor that has been studied as monotherapy and as an adjunctive therapy to other oral agents in a dual or triple combination regimen. It is effective in lowering glycosylated hemoglobin and has a favorable safety profile.
Paper Details　
Original Abstract of the Article :
Dipeptidyl peptidase-4 (DPP-4) inhibitors are some of the newest medications in our armamentarium for the management of type 2 diabetes mellitus. Through inhibition of the DPP-4 enzyme, these agents increase the amount of circulating incretin hormones, leading to an increase in insulin release and a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/22143285

データ提供：米国国立医学図書館（NLM）

Linagliptin: A New Weapon in the Arsenal Against Type 2 Diabetes

This research, like a beacon in the vast desert of diabetes research, shines a light on linagliptin, a new dipeptidyl peptidase-4 (DPP-4) inhibitor. The authors explain how linagliptin works, enhancing the body's natural ability to regulate blood sugar levels. They meticulously analyze the efficacy and safety of linagliptin, highlighting its potential benefits for individuals with type 2 diabetes, particularly those with kidney impairment. Their research, like a carefully constructed oasis, provides valuable insights into the latest advancements in diabetes management.

Linagliptin: A Promising Addition to Diabetes Treatment

Linagliptin, like a refreshing spring in the desert, offers a new approach to managing type 2 diabetes. This medication demonstrates impressive efficacy and a favorable safety profile, presenting a promising alternative for individuals seeking to improve their blood sugar control.

Managing Type 2 Diabetes: Finding the Right Path

This research highlights the importance of personalized treatment plans for individuals with type 2 diabetes. With the emergence of new medications like linagliptin, healthcare professionals have more tools to help patients navigate the desert of diabetes management and achieve optimal health outcomes.

Dr.Camel's Conclusion

Linagliptin, like a sturdy camel, carries the potential to help those with type 2 diabetes journey towards better blood sugar control. This research provides valuable insights into this promising new treatment option, offering hope for a more balanced and healthy future.
Date :
  1. Date Completed 2012-02-14
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

22143285

DOI: Digital Object Identifier

00045415-201201000-00008

Related Literature

Article Analysis
・Side Effects of linagliptin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.